Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.
Also called NCT02545933
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 130 participants
- Registry
-
NCT02545933
-
- Other papers using this trial's data
- Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y12 Receptor Inhibitors With and Without Aspirin: Results of the VORA-PRATIC Study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02545933. Randomized; no masking; primary purpose treatment. Start 2016-02 (actual); primary completion 2019-05 (actual). Results posted on 2020-08-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor
- Acronym
- VORA-PRATIC
- Condition
- Myocardial Infarction
- Intervention (Drug)
- Prasugrel
- Intervention (Drug)
- Vorapaxar
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- University of Florida
- Collaborator
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct02545933- Content hash
7e5bcd59c83883da8c2467cc76202ae4d7ab81d7256116150b75e1a03de6e481